<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01814956</url>
  </required_header>
  <id_info>
    <org_study_id>HC-G-H-0813</org_study_id>
    <secondary_id>2011-003397-82</secondary_id>
    <nct_id>NCT01814956</nct_id>
  </id_info>
  <brief_title>Different Lipid Emulsions in Acute Lung Injury Patients</brief_title>
  <official_title>Prospective, Randomized, Controlled, Double-blind, Parallel-group, Mono-center, Explorative Phase IV Trial on the Efficacy and Safety of a Fish Oil Containing Lipid Emulsion Versus a Standard Soybean-oil Based Lipid Emulsion in Patients With Acute Lung Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B. Braun Melsungen AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>B. Braun Melsungen AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim is to investigate the influence of an early supply of parenteral nutrition including a
      fish oil containing lipid emulsion on the course of acute lung injury in the intensive care
      unit. In comparison, a standard parenteral nutrition with a soybean oil based emulsion will
      be used. Data obtained in this trial may provide evidence for a beneficial effect of fish oil
      derived omega-3 fatty acids in parenteral nutrition regarding their influence on acute lung
      injury.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low recruitment
  </why_stopped>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in blood oxygenation (PaO2/FiO2ratio)</measure>
    <time_frame>change day 1 to day 6</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>day 1 to day 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sequential Organ Failure Assessment</measure>
    <time_frame>day 1 to day 28</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Parenteral Nutrition</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>i.v. lipid emulsion for parenteral nutrition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>i.v. lipid emulsion for parenteral nutrition</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lipoplus 20%</intervention_name>
    <description>Lipoplus 20% (MCT/LCT/FO) i.v. lipid emulsion for parenteral nutrition</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lipofundin N 20%</intervention_name>
    <description>Lipofundin N 20% (LCT, soy bean oil) i.v. lipid emulsion for parenteral nutrition</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:

          -  Acute Lung Injury as a result of proven pneumonia (x-ray) or witnessed aspiration

          -  Oxygenation factor ≤ 300

          -  &lt;= 72 hours since intubation or non-invasive ventilatory support by mask at screening

          -  Expected need for parenteral nutrition for at least 5 days

          -  Male or female ≥ 18 years of age

        Exclusion:

          -  Exclusion of pregnancy in women with child-bearing potential

          -  Cardiogenic pulmonary oedema

          -  Previous (&lt; 1 month) or ongoing need for corticosteroids &gt;0.1 mg/kg/d
             prednisolon-equivalent or other immune suppressive treatment

          -  Active or previous (&lt; 1 year) treatment for solid or haematologic malignancy

          -  Serum triglycerides &gt; 300 mg/dl at screening

          -  Alterations of coagulation (thrombocytes &lt;100 Giga/l), aPTT &gt; 60 sec, INR ≥ 2.5
             without therapeutic intervention

          -  Autoimmune disease or HIV (according to medical history)

          -  Known or suspected drug abuse

          -  General contraindications to infusion therapy :
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Clinic Giessen</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2013</study_first_submitted>
  <study_first_submitted_qc>March 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2013</study_first_posted>
  <last_update_submitted>July 19, 2016</last_update_submitted>
  <last_update_submitted_qc>July 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

